Ask AI

Advancing the Early Detection of Lung Cancer: A Multipronged Educational Initiative to Elevate Evidence-Based Screening Practices

Start Activity
Video
Video Start Activity
This activity is available for 1.00 CME/CE credit(s).

Released: September 08, 2026

Expiration: March 07, 2027

See Activity Collection

Step 1 of 5

1 Pre Assessment 2 Video 3 Post Assessment 4 Evaluation 5 Credit

In this on-demand webcast, an expert reviews the evidence supporting low-dose CT screening for lung cancer and examines how current eligibility criteria, risk factors, and implementation barriers affect early detection in clinical practice. The activity highlights landmark randomized data from NELSON and the National Lung Screening Trial demonstrating reductions in lung cancer mortality with screening while comparing current screening guidelines for eligibility. The expert also explores limitations of age- and pack-year–based criteria, disparities in screening access and eligibility, and emerging evidence supporting broader risk assessment that incorporates factors such as family history, occupational and environmental exposures, race and ethnicity, and risk prediction models. Practical strategies for improving screening uptake, including shared decision-making, centralized screening programs, navigation, electronic health record prompts, and patient-centered communication, are discussed alongside emerging approaches that may help identify high-risk individuals who fall outside current screening guidelines.

Neel P. Chudgar
Neel P. Chudgar, MD
Early Detection of Lung Cancer

Pre Assessment

Assess your current knowledge and clinical approach before beginning your video.
Begin Your Video
1.

How many people do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Which of the following has the greatest influence on limiting the broad use of low-dose CT screening for lung cancer in clinical practice?

4.

Please indicate your level of agreement with this statement: In my current practice, I discuss lung cancer screening with all eligible patients according to the USPSTF 2021 guidelines.

5.

Which of the following patients of “ever smokers” represents the highest (immediate/current) statistical risk for lung cancer that could be mitigated using low-dose CT screening to improve early detection?

6.

A patient hesitant about lung cancer screening asks whether his family history of lung cancer and his borderline-eligible smoking history are enough to justify low-dose CT.

Which of the following is the most appropriate counseling response to communicate?

7.

Does using risk prediction models represent a barrier to wider implementation of lung cancer screening in primary care?

Begin Your Video